Renovacor, Inc.
RCORDelisted Dec 1, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001799850
Renovacor, Inc. was delisted on Dec 1, 2022; its insiders filed their last Form 4 on Apr 5, 2023; 27 institutions reported holding it in 13F filings for Q3 2022, worth $18.4M in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Renovacor, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- +1 vs. Q4 2021
- Shares held
- 7.98M
- +393.6K (+5.2%) vs. Q4 2021
- Total value
- $33.8M
- −$24.6M (−42.1%) vs. Q4 2021
- New holders
- 2
- 6 more added
- Sold out
- 1
- 6 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RCOR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 27 | $18.4M |
| Q2 2022 | 24 | $16.0M |
| Q1 2022 | 24 | $33.8M |
| Q4 2021 | 23 | $58.4M |
| Q3 2021 | 22 | $64.5M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Renovacor, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| RTW Investments, LP | 3,000,803 | $12.7M | 0.26% | +353,263+13.3% | Added |
| Citadel Advisors LLC | 1,054,406 | $4.47M | 0.01% | +1,782+0.2% | Added |
| Sio Capital Management, LLC | 735,908 | $3.12M | 1.26% | 00.0% | Unchanged |
| New Leaf Venture Partners, L.L.C. | 672,288 | $2.85M | 1.41% | −25,148−3.6% | Reduced |
| Cormorant Asset Management, LP | 500,000 | $2.12M | 0.16% | 00.0% | Unchanged |
| Vanguard Group Inc | 415,758 | $1.76M | 0.00% | −2,729−0.7% | Reduced |
| Altium Capital Management LP | 388,845 | $1.65M | 0.57% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 343,283 | $1.46M | 0.44% | +381+0.1% | Added |
| Affinity Asset Advisors, LLC | 199,490 | $846.0K | 0.34% | +74,490+59.6% | Added |
| 683 Capital Management, LLC | 175,000 | $742.0K | 0.04% | 00.0% | Unchanged |
| Pura Vida Investments, LLC | 145,390 | $616.0K | 0.07% | −5,115−3.4% | Reduced |
| HRT Financial LP | 102,894 | $436.0K | 0.00% | −14,420−12.3% | Reduced |
| Kepos Capital LP | 100,000 | $424.0K | 0.03% | 00.0% | Unchanged |
| Morgan Stanley | 53,035 | $225.0K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 31,979 | $136.0K | 0.00% | −1,918−5.7% | Reduced |
| Geode Capital Management, LLC | 23,001 | $97.0K | 0.00% | +23,001 | New |
| Northern Trust Corp | 16,861 | $71.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 11,829 | $50.0K | 0.00% | +11,829 | New |
| Wolverine Asset Management LLC | 3,265 | $13.0K | 0.00% | +2,335+251.1% | Added |
| UBS Group AG | 1,892 | $8.00K | 0.00% | +1,362+257.0% | Added |
| Tower Research Capital LLC (TRC) | 873 | $3.00K | 0.00% | −147−14.4% | Reduced |
| BlackRock Inc. | 617 | $3.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 200 | $1.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 64 | $0 | 0.00% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −25,321−100.0% | Sold out |